Modelled DT Structure
Method: homology modeling
Template PDB: 4XP9_C
Identity: 47.292%
Minimized Score: -1471.995 kcal/mol
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0444 | ||||
Gene Name | SLC6A12 | ||||
Protein Name | Na(+)/Cl(-) betaine/GABA transporter | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: homology modeling Template PDB: 4XP9_C Identity: 47.292% Minimized Score: -1471.995 kcal/mol Detail: Structure Info |
||||
Synonyms | BGT-1; BGT1; SLC6A12; Sodium- and chloride-dependent betaine transporter; Solute carrier family 6 member 12 | ||||
DT Family | Neurotransmitter:Sodium Symporter (NSS) Family ; | ||||
Tissue Specificity | Liver, heart, skeletal muscle, placenta, and awidespread distribution in the brain. | ||||
Function | This transporter may have a role in regulation of GABAergic transmission in the brain through the reuptake of GABA into presynaptic terminals, as well as in osmotic regulation. Transports betaine and GABA. | ||||
Disease(s) | Inborn error of metabolism [ICD-11: 5D2Z] | ||||
Malaria [ICD-11: 1F40] | |||||
Endogenous Substrate(s) | Diaminobutyrate; Dimethylglycine; Gamma-aminobutyric acid; Na+ | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
(ε) Exogenous Modulation of This DT |
|||||
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
(β) Inter-species Structural Differences |
|||||
(γ) Outward/inward-facing Conformation |
|||||
(δ) Xenobiotics-regulated Structural Variability |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(α) Genetic Polymorphisms of This DT |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Approved Drug |
Click to Show/Hide the Full List of Drug: 4 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
Betaine
|
Approved | Drug Info | Inborn error of metabolism | 5D2Z | [1] |
Glycine
|
Approved | Drug Info | Dietary shortage | 5B7Z | [2] |
L-proline
|
Approved | Drug Info | Dietary shortage | 5B7Z | [2] |
Quinine
|
Approved | Drug Info | Malaria | 1F40 | [3] |
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
Choline
|
Phase 3 | Drug Info | Elderly bronchial asthma | CA23 | [2] |
References | |||||
1 | Deletion of the betaine-GABA transporter (BGT1; slc6a12) gene does not affect seizure thresholds of adult mice. Epilepsy Res. 2011 Jun;95(1-2):70-81. | ||||
2 | Interpreting metabolomic profiles using unbiased pathway models. PLoS Comput Biol. 2010 Feb 26;6(2):e1000692. | ||||
3 | The Transporter Classification Database (TCDB): recent advances. Nucleic Acids Res. 2016 Jan 4;44(D1):D372-9. (ID: 2.A.22.3.1) | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.